AzTrials
AzTrials

PeriodontitisNCT05088746

Comparing Different Timings for Periodontal Re-evaluation After Non-surgical Periodontal Therapy (NSPT)

An observational study of Periodontitis and Periodontal Pocket, run by University of Parma at 1 site in Italy.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This is a prospective cohort study that aims to describe the difference in terms of percentage of closed pockets (PPD <5 mm and no BOP) when performing the periodontal re-evaluation at 3-4, 6-8 and 12 months. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Periodontitis, Periodontal Pocket
What is being tested?
Non-surgical periodontal therapy
Type of treatment
Surgery or procedure
How many people
52 participants
Where
1 siteItaly
Study dates
1 Jun 2021to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients affected by periodontitis

Who may be able to join

  • Systemically healthy males and females ≥18 years old
  • Willingness to read and sign a copy of the Informed Consent Form after reading the Patient Information Sheet, and after the nature of the study has been fully explained
  • Clinical evidence of periodontitis, defined as the presence of interdental clinical attachment loss detectable at ≥2 non-adjacent teeth or buccal or oral clinical attachment loss ≥3mm with pocketing >3 mm detectable at ≥2 teeth (Tonetti et al., 2018)
  • Not having received subgingival instrumentation within the previous 12 months

Who cannot join

  • Medical history that includes serious medical conditions or transmittable diseases (e.g. serious cardiovascular disease, organ transplant, renal failure, AIDS, viral etc.).
  • Antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.
  • In treatment with drugs that induce gingival overgrowth
  • History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
  • History of alcohol or drug abuse.
  • Self-reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing, which can affect interpretation of study results).
  • Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or investigational product administration or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Centro Universitario di Odontoiatria

    Parma

Other trials in Italy

About this study

This is a prospective cohort study that aims to describe the difference in terms of percentage of closed pockets (PPD <5 mm and no BOP) when performing the periodontal re-evaluation at 3-4, 6-8 and 12 months.

Fifty-two, ≥18-year old, otherwise healthy, periodontitis patients will be recruited at Centro di Odontoiatria, Università di Parma.

Read the detailed description

This is a prospective cohort study describing the difference in terms of percentage of closed pockets (PPD <5 mm and no BOP) when performing the periodontal re-evaluation at 3-4, 6-8 or 12 months. The trial will follow the recommendations of the Consolidated Standards of Reporting Trials (CONSORT) statement. The study consists of 7 visits over a period of 15 months.

Visit 1 - Baseline -

  • Informed consent, medical/dental history and demographics
  • Record concomitant medications and smoking history
  • Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
  • Standardized peri-apical x-rays for the sites with PPD≥5mm, as per standard of practice (if not already available within the previous 6 months)
  • Intra-oral 3D scan
  • Oral hygiene instructions and demonstration of self-performed oral hygiene measures
  • PROMs questionnaires
  • Saliva collection and GCF collection from the deepest pockets (maximum of 5 sites)

Visit 2 and 3 - NSPT - (and extra visit 3.1 and 3.2 if needed) (within 60 days from baseline)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • NSPT, consisting in the careful removal of hard and soft deposits with ultrasonic instruments at infected sites performed by an experienced clinician following the principles of minimally invasive non-surgical therapy (MINST). A quadrant approach will be adopted and it will be left to the discretion of the clinician to choose whether to instrument 1 or 2 quadrants at a time and the length of session visits. Hence, 2 to 4 sessions of NSPT with an interval of 1 week between each other will be performed. During NSPT, teeth considered hopeless will be extracted as per standard of practice.
  • Reinforcement of oral hygiene instructions
  • PROMs questionnaires

Extra visits outside the study protocol may be arranged in case the patients need extractions or other dental treatments besides NSPT.

Visit 4 (4-6 weeks from the end of NSPT)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • Visual inspection of signs of inflammation and plaque
  • Supragingival polish and reinforcement of oral hygiene instructions
  • PROMs questionnaires
  • Intra-oral 3D scan

Visit 5 (3-4 months from the end of NSPT)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
  • PROMs questionnaires
  • Intra-oral 3D scan
  • Saliva collection and GCF collection from the same sites identified at baseline
  • Supragingival polish and reinforcement of oral hygiene instructions

Visit 6 (6-8 months from the end of NSPT)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
  • PROMs questionnaires
  • Intra-oral 3D scan
  • Saliva collection and GCF collection from the same sites identified at baseline
  • Supragingival polish and reinforcement of oral hygiene instructions

Visit 7 (12 months ± 14 days from the end of NSPT)

  • Update medical/dental history and record adverse events and/or concomitant medications
  • Periodontal assessment by a blind and calibrated examiner, consisting of full mouth PPD, REC, BOP, PI, mobility and furcation involvement. PPD, REC, PI and BOP will be recorded at 6 sites per tooth.
  • PROMs questionnaires
  • Intra-oral 3D scan
  • Standardized peri-apical x-rays
  • Saliva collection and GCF collection from the same sites identified at baseline
  • Supragingival polish and reinforcement of oral hygiene instructions

Photos and videos may be taken/recorded in any of the study visits for documentation purposes. The subject will not be identifiable from those photos/videos.

Being tested
Non-surgical periodontal therapy
Medical subject headings
Periodontitis, Periodontal Pocket

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-surgical periodontal therapyProcedure or surgery

    NSPT will be performed following the principles of minimally invasive non-surgical therapy (MINST) described by Nibali et al. (Nibali et al., 2015, Nibali et al., 2019)

Study groups in NCT05088746
Study groupRoleWhat they receive
Non-surgical periodontal therapyNot described
Receives: Procedure: Non-surgical periodontal therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. changes in percentage of closed pockets (PPD <5 mm and no BOP)

    Measured: From baseline to 3-4; 6-8 and 12 months

Secondary outcomes (8)
  1. Changes in probing pocket depth (PPD), recession (REC) and clinical attachment level (CAL)

    Measured: From baseline to 3-4; 6-8 and 12 months

  2. Changes in the percentages of sites with PPD reduction ≥2mm

    Measured: From baseline to 3-4; 6-8 and 12 months

  3. Changes in the percentages of sites with CAL gain ≥2mm

    Measured: From baseline to 3-4; 6-8 and 12 months

  4. Changes in the percentage of deep pockets (PPD≥6 mm)

    Measured: From baseline to 3-4; 6-8 and 12 months

  5. Evaluation of global changes in quality of life

    In all post NSPT re-evaluations (Visit 4 to 7), a questionnaire (2 questions) will be given to participants to assess changes in quality of life following periodontal therapy

    Measured: 4-6 weeks; 3-4 months; 6-8 months; 12 months

  6. changes in oral impact on daily performance (OIDP)

    Self-administered questionnaire, it is a composite measure of the impacts of oral health on the quality of life of people.

    Measured: From baseline to 4-6 weeks; 3-4 months; 6-8 months; 12 months

  7. Changes in global ratings of periodontal health and quality of life

    self administered questionnaire and VAS scale

    Measured: From baseline to 4-6 weeks; 3-4 months; 6-8 months; 12 months

  8. Evaluation of changes in patient perception about therapy

    VAS scale to evaluate patient perception about therapy

    Measured: From non-surgical therapy visit to 4-6 weeks follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2021
  2. Study start1 Jun 2021
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05088746
Sponsor's protocol ID
P-002
Status last verified
Jul 2026
First submitted
27 May 2021
Last updated
7 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Centro di Odontoiatria is the sponsor for this study. We will be using patient information in order to undertake this study and will act as the data controller for this study. This means that we are responsible for looking after patient information and using it properly. We will keep identifiable information for 20 years after the study has finished. The only people within the Centro di Odontoiatria who will have access to information that identifies the patients will be people who need to contact them about the research study, and make sure that relevant information about the study is recorded for their care, and to oversee the quality of the study or audit the data collection process. The people who analyse the information will not be able to identify patients and will not be able to find out their name or contact details.

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontitis and Periodontal Pocket, run by University of Parma at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

changes in percentage of closed pockets (PPD <5 mm and no BOP) (time frame: From baseline to 3-4; 6-8 and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in